Analysts Set Beam Therapeutics Inc. (NASDAQ:BEAM) Price Target at $46.08
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has received an average rating of “Hold” from the twelve brokerages that are currently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target […]
More Stories
What Documents Do You Need to Hire International Employees?
Hiring talent from abroad can move your business forward; however, paperwork decides how fast you move. You need clear records...
DOJ Inquiry Into Fed Chair: What to Know
By Andrew Moran The Federal Reserve was thrust into the spotlight on Jan. 11, after chair Jerome Powell said the...
Their Bodies Were Irreversibly Damaged, Now These Former Transgender Teens Are Fighting for Justice
By Darlene McCormick Sanchez Young people who used to identify as transgender have filed dozens of lawsuits in the past...
Hegseth Says Proposed $1.5 Trillion Military Budget Is ‘Message to the World’
By Ryan Morgan War Secretary Pete Hegseth on Jan. 12 said President Donald Trump’s call for a $1.5 trillion military...
Treasury Secretary Says US Can Easily Cover Any Tariff Refunds
By Jack Phillips Treasury Secretary Scott Bessent said that his department can easily cover any refunds related to tariffs if...
Conrad Black: How US Action Against the Iranian Regime Could Play Out
By Conrad Black The world is waiting for President Trump to bring the horrible and sanguinary disaster of the last...